Literature DB >> 3024760

Immunogenic nature of a Pol gene product of HTLV-III/LAV.

J S Allan, J E Coligan, T H Lee, F Barin, P J Kanki, S M'Boup, M F McLane, J E Groopman, M Essex.   

Abstract

The present studies were initiated to define the coding region of a 34 kilodalton (kd) protein (p34) frequently observed with antibodies from HTLV-III/LAV-infected people by immunoblotting and radioimmunoprecipitation (RIP) techniques. We have directly mapped this viral protein to the pol gene of HTLV-III/LAV by radiolabeled amino acid sequence analysis. This region at the 3' end of the pol gene is predicted to encode the endonuclease/integrase of the virus. The seroprevalence rate of antibodies to the pol gene products p64 and p53 and to the endonuclease p34 were evaluated. Of 161 HTLV-III/LAV seropositive people tested by immunoblotting procedures, greater than 98% had antibodies which reacted to p64/p53 and 92.6% reacted to p34 indicating that these viral proteins are highly immunogenic in nature. We have also analyzed the serum of nine healthy people living in West Africa who were infected with HTLV-IV, a closely related retrovirus. Nine of nine seropositive people had antibodies that cross-reacted to p34 of HTLV-III/LAV, whereas only seven of nine reacted to p64/p53. These studies and our earlier observations indicate that current diagnostic procedures for screening for HTLV-III/LAV infection may also detect HTLV-IV seropositive individuals, pointing to a need for more specific assay systems.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3024760

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Species-specific diversity among simian immunodeficiency viruses from African green monkeys.

Authors:  J S Allan; M Short; M E Taylor; S Su; V M Hirsch; P R Johnson; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Identification of a uniquely immunodominant, cross-reacting site in the human immunodeficiency virus endonuclease protein.

Authors:  E Björling; G Utter; P Stålhandske; E Norrby; F Chiodi
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.

Authors:  Francis Barin; Laurence Meyer; Rémi Lancar; Christiane Deveau; Myriam Gharib; Anne Laporte; Jean-Claude Desenclos; Dominique Costagliola
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Cross-sectional study of reverse transcriptase-inhibiting antibody as a marker of acquired immune deficiency syndrome.

Authors:  M Advani; D T Imagawa; M H Lee; K Sano; F Morales; R T Mitsuyasu; R Detels
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

5.  Pattern of transcription of the genome of equine infectious anemia virus.

Authors:  S Noiman; A Yaniv; L Sherman; S R Tronick; A Gazit
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Two highly antigenic sites in the human immunodeficiency virus type 1 reverse transcriptase.

Authors:  E Björling; C A Boucher; A Samuelsson; T F Wolfs; G Utter; E Norrby; F Chiodi
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

7.  Characteristics and clinical significance of a stabilization assay to detect specific antibodies to reverse transcriptase of human immunodeficiency virus.

Authors:  M Morita; T Suzuki; K Nakajima; C Shiozawa; M J Gill; H Hoshino
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

8.  Major antigenic region on the integrase (IN) protein of human immunodeficiency virus type 1 determined by reactivity of human sera and a monoclonal antibody to IN protein.

Authors:  Y Tachibana; A Yasuda; T Kurata; S Oka; K Shimada; A Kojima
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

9.  Comparison of 10 enzyme immunoassays for detection of antibody to human immunodeficiency virus type 2 in West African sera.

Authors:  F Denis; G Leonard; A Sangare; G Gershy-Damet; J L Rey; B Soro; D Schmidt; M Mounier; M Verdier; A Baillou
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

10.  Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24.

Authors:  F D Veronese; T D Copeland; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.